IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 366 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $331,672 | +12.7% | 7,312 | +2.0% | 0.03% | +14.8% |
| Q2 2023 | $294,226 | -38.3% | 7,171 | -43.2% | 0.03% | -70.3% |
| Q4 2022 | $476,808 | +5.3% | 12,624 | +23.2% | 0.09% | -3.2% |
| Q3 2022 | $453,000 | 0.0% | 10,248 | -16.2% | 0.09% | -45.7% |
| Q2 2022 | $453,000 | +62.9% | 12,225 | +62.6% | 0.17% | +66.3% |
| Q1 2022 | $278,000 | -22.8% | 7,518 | -36.5% | 0.10% | +8.3% |
| Q4 2021 | $360,000 | +6.2% | 11,845 | +106.0% | 0.10% | +28.0% |
| Q2 2020 | $339,000 | 0.0% | 5,749 | -19.8% | 0.08% | -93.1% |
| Q1 2020 | $339,000 | – | 7,168 | – | 1.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,529,838 | $404,393,000 | 11.39% |
| DOWLING & YAHNKE LLC | 676,379 | $41,888,000 | 5.27% |
| Opus Point Partners Management, LLC | 102,459 | $6,345,000 | 4.19% |
| WILLIAM HARRIS INVESTORS INC | 230,443 | $14,271,000 | 3.43% |
| PINNACLE ASSOCIATES LTD | 1,690,263 | $104,678,000 | 2.20% |
| MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ | 21,298 | $1,319,000 | 2.11% |
| Sonora Investment Management, LLC | 126,763 | $7,850,000 | 2.04% |
| Virtus ETF Advisers LLC | 10,447 | $647,000 | 1.78% |
| Apex Capital Management | 1,020,096 | $63,175,000 | 1.41% |
| PERKINS CAPITAL MANAGEMENT INC | 19,900 | $1,232,000 | 1.32% |